Ex Parte Schoonderwoerd et al - Page 5




          Appeal No. 2002-1653                                                        
          Application No. 09/543,336                                                  


          within the province of this Board to ferret out evidence from               
          appellants' specification which supports a conclusion of                    
          nonobviousness.                                                             
               The thrust of appellants' argument is directed towards Hoy,            
          the secondary reference.  As explained by the examiner, however,            
          appellants have failed to address the specific disclosure in Chen           
          of utilizing 1.5 mols of acetoacetate per mol of crosslinker.               
          While appellants state at page 4 of the Reply Brief that the                
          examiner "erroneously states that Appellants have not addressed             
          his arguments regarding the cited prior art" (penultimate                   
          paragraph), appellants' Reply Brief persists in not confronting             
          Chen's disclosure of the preferred ratio that falls directly                
          within the claimed range.  Appellants do not shoulder their                 
          burden of refuting the examiner's rejection by offering the                 
          conclusion that "[i]t is akin to comparing the proverbial apples            
          and oranges to compare Chen with the Appellants' [sic,                      
          Appellants'] invention" (id.).  It is incumbent upon appellants             
          to cite facts to support their "apples and oranges" analogy.  The           
          principal and reply briefs, however, are fatally deficient in               
          presenting such facts.                                                      





                                         -5-                                          




Page:  Previous  1  2  3  4  5  6  7  Next 

Last modified: November 3, 2007